Medium materiality6/10
Jefferies raises AXGN price target to $60
Why it may matterVerify against the original reporting
Bullish analyst revision with meaningful implied upside, though a price target alone is not a fundamental catalyst.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Jefferies raised its AxoGen target from $55 to $60, versus a posted price of $49.25, implying roughly 22% upside to the new target.
- Target increased by $5 to $60.
- Posted price: $49.25.
Key facts
- 01
Target: $60
- 02
Posted price: $49.25
- 03
Analyst firm: Jefferies
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.